NR4A1 and breast carcinoma: On the other hand, unlike breast cancers arising in non-BRCA carriers, hormone receptor status had no prognostic value in young BRCA-mutated patients, and even a tendency of worse DRFI in women with hormone receptor-positive disease was observed.